These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38979260)

  • 1. Stabilization of GTSE1 by cyclin D1-CDK4/6 promotes cell proliferation: relevance in cancer prognosis.
    García-Vázquez N; González-Robles TJ; Lane E; Spasskaya D; Zhang Q; Kerzhnerman M; Jeong Y; Collu M; Simoneschi D; Ruggles KV; Rona G; Pagano M; Kaisari S
    bioRxiv; 2024 Jun; ():. PubMed ID: 38979260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity.
    Lukas J; Bartkova J; Rohde M; Strauss M; Bartek J
    Mol Cell Biol; 1995 May; 15(5):2600-11. PubMed ID: 7739541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
    Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
    Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B cell antigen receptor-mediated activation of cyclin-dependent retinoblastoma protein kinases and inhibition by co-cross-linking with Fc gamma receptors.
    Tanguay D; Pavlovic S; Piatelli MJ; Bartek J; Chiles TC
    J Immunol; 1999 Sep; 163(6):3160-8. PubMed ID: 10477583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SREBP-dependent regulation of cyclin D1 coordinates cell proliferation and lipid synthesis.
    Aldaalis A; Bengoechea-Alonso MT; Ericsson J
    Front Oncol; 2022; 12():942386. PubMed ID: 36091143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic AMP negatively controls c-myc transcription and G1 cell cycle progression in p210 BCR-ABL transformed cells: inhibitory activity exerted through cyclin D1 and cdk4.
    Williamson EA; Burgess GS; Eder P; Litz-Jackson S; Boswell HS
    Leukemia; 1997 Jan; 11(1):73-85. PubMed ID: 9001421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for Cyclin D1 function in G1 progression.
    Tam SW; Theodoras AM; Shay JW; Draetta GF; Pagano M
    Oncogene; 1994 Sep; 9(9):2663-74. PubMed ID: 8058330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D-Cdk4,6 Drives Cell-Cycle Progression via the Retinoblastoma Protein's C-Terminal Helix.
    Topacio BR; Zatulovskiy E; Cristea S; Xie S; Tambo CS; Rubin SM; Sage J; Kõivomägi M; Skotheim JM
    Mol Cell; 2019 May; 74(4):758-770.e4. PubMed ID: 30982746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 promotes cell cycle progression through enhancing NDR1/2 kinase activity independent of cyclin-dependent kinase 4.
    Du Z; Tong X; Ye X
    J Biol Chem; 2013 Sep; 288(37):26678-87. PubMed ID: 23897809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role of cyclin D1 nuclear import in cardiomyocyte proliferation.
    Tamamori-Adachi M; Ito H; Sumrejkanchanakij P; Adachi S; Hiroe M; Shimizu M; Kawauchi J; Sunamori M; Marumo F; Kitajima S; Ikeda MA
    Circ Res; 2003 Jan; 92(1):e12-9. PubMed ID: 12522130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphenol S promotes the cell cycle progression and cell proliferation through ERα-cyclin D-CDK4/6-pRb pathway in MCF-7 breast cancer cells.
    Lin Z; Zhang X; Zhao F; Ru S
    Toxicol Appl Pharmacol; 2019 Mar; 366():75-82. PubMed ID: 30684532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of cyclin D1-Cdk4 and Cdk4-directed phosphorylation of RB protein in diabetic mesangial hypertrophy.
    Féliers D; Frank MA; Riley DJ
    Diabetes; 2002 Nov; 51(11):3290-9. PubMed ID: 12401721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the p16/cyclin D1/CDK4/Rb/E2F1 pathway on aberrant lung fibroblast proliferation in neonatal rats exposed to hyperoxia.
    Zhao S; Chen Z; Han S; Wu H
    Exp Ther Med; 2021 Oct; 22(4):1057. PubMed ID: 34434271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein.
    Pan W; Cox S; Hoess RH; Grafström RH
    Cancer Res; 2001 Apr; 61(7):2885-91. PubMed ID: 11306463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression.
    Grillo M; Bott MJ; Khandke N; McGinnis JP; Miranda M; Meyyappan M; Rosfjord EC; Rabindran SK
    Breast Cancer Res Treat; 2006 Jan; 95(2):185-94. PubMed ID: 16319987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer.
    Peurala E; Koivunen P; Haapasaari KM; Bloigu R; Jukkola-Vuorinen A
    Breast Cancer Res; 2013 Jan; 15(1):R5. PubMed ID: 23336272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baicalein induces G1 arrest in oral cancer cells by enhancing the degradation of cyclin D1 and activating AhR to decrease Rb phosphorylation.
    Cheng YH; Li LA; Lin P; Cheng LC; Hung CH; Chang NW; Lin C
    Toxicol Appl Pharmacol; 2012 Sep; 263(3):360-7. PubMed ID: 22820424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibition of human MDA-mB-231 breast cancer cells by delta-tocotrienol is associated with loss of cyclin D1/CDK4 expression and accompanying changes in the state of phosphorylation of the retinoblastoma tumor suppressor gene product.
    Elangovan S; Hsieh TC; Wu JM
    Anticancer Res; 2008; 28(5A):2641-7. PubMed ID: 19035289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Clinicopathological Significance of the Cyclin D1/E1-Cyclin-Dependent Kinase (CDK2/4/6)-Retinoblastoma (RB1/pRB1) Pathway in Epithelial Ovarian Cancers.
    Lashen A; Algethami M; Alqahtani S; Shoqafi A; Sheha A; Jeyapalan JN; Mongan NP; Rakha EA; Madhusudan S
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
    Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.